Synopsys, Inc. (Nasdaq: SNPS) today announced the expansion of its hardware-assisted verification (HAV) portfolio with new ...

Universities and colleges are sprawling organizations. Over time, some end up using disparate email systems and office ...

The Minnesota Twins have had good luck signing players out of independent ball, including Caleb Thielbar, Andrew Albers, and ...

FlyFreely expands their US market as a new LAANC provider, expanding drone management capabilities for U.S. operators.

Journalists typically treat corruption as an issue of governance. However, dishonesty is not an attribute of constitutional ...

Bryant Junco, who is running in Tuesday's primary for the Milwaukee Common Council seat, has faced accusations of from eight women in three states.

Multi-signature (multi-sig) wallets require multiple approvals for transactions, increasing security. Proper key generation ...

By investing in real-time data capabilities sooner, we can build a sustainable future that’s not just efficient but ...

Despite the latest AI advancements, Large Language Models (LLMs) continue to face challenges in their integration into the ...

Double storms from south of the border are lining up to bring heavy snow to Ontario, Quebec and Atlantic Canada through to the middle of February.

The FDA has granted Fast Track Designation to Lundbeck’s investigational drug, amlenetug, a potential new treatment option targeting Multiple System Atrophy (MSA).

As an iron chaperone, it has excellent potential to treat Parkinson’s disease as well as various Parkinsonian disorders such as Multiple System Atrophy (MSA). ATH434 successfully completed Phase ...